V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004778 | 280003214 | 1.49 | 67 | null | 2014-12-17 | 2014-12-30 | CARBOPLATIN + PACLITAXEL | 02 | N | 280027943 | CARBOPLATIN + PACLITAXEL |
| 280004779 | 280003214 | 1.67 | 91.5 | Adjuvant (A) | 2014-11-17 | 2014-11-25 | Carboplatin AUC 2 - 5 | 02 | N | 280027943 | CARBOPLATIN |
| 280004780 | 280003215 | 0 | null | Adjuvant (A) | 2014-09-06 | 2014-10-04 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | 280027948 | NOT MATCHED |
| 280004781 | 280007644 | 1.77 | 90.3 | Curative (C) | 2014-11-24 | 2014-11-24 | Carboplatin + Etoposide iv&po | null | null | 280027949 | CARBOPLATIN + ETOPOSIDE |
| 280004782 | 280003216 | 1.85 | 73 | Curative (C) | 2014-04-18 | 2014-05-10 | Cetuximab 7 day (Cycle 1) | N | Y | 280027951 | CETUXIMAB |
| 280004783 | 280007645 | 1.5 | 68.1 | Adjuvant (A) | 2016-03-03 | 2016-03-24 | Carboplatin + Etoposide iv&po | 2 | N | 280027952 | CARBOPLATIN + ETOPOSIDE |
| 280004784 | 280003217 | 1.52 | null | Curative (C) | 2015-03-20 | 2015-03-20 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280027954 | CARBOPLATIN + PACLITAXEL |
| 280004785 | 280007646 | 1.6 | null | Adjuvant (A) | null | 2014-08-19 | EW EuroEwing 2012 Arm B VDC | null | null | 280027955 | TRIAL |
| 280004786 | 280003218 | 0 | 65.2 | Adjuvant (A) | 2014-01-01 | 2014-01-02 | EW EuroEwing 2012 Arm B VDC | N | Y | 280027960 | TRIAL |
| 280004787 | 280003219 | 1.67 | null | Curative (C) | 2015-03-21 | 2015-04-24 | Trial Unspecified | 02 | N | 280027961 | TRIAL |
| 280004788 | 280003219 | 1.55 | 60.4 | Curative (C) | 2017-01-14 | 2017-01-17 | Carboplatin + Paclitaxel (3 weekly) | N | null | 280027961 | CARBOPLATIN + PACLITAXEL |
| 280004789 | 280003219 | 1.71 | 57.1 | Curative (C) | 2013-06-30 | 2013-07-29 | CARBOPLATIN + RT | N | Y | 280027961 | CARBOPLATIN + RT |
| 280004790 | 280003220 | 1.47 | 56.8 | Adjuvant (A) | null | 2016-03-26 | Trial Unspecified | N | Y | 280027967 | TRIAL |
| 280004791 | 280003220 | 1.63 | 56.4 | Curative (C) | 2015-09-28 | 2015-10-12 | CARBOPLATIN + RT | N | Y | 280027967 | CARBOPLATIN + RT |
| 280004792 | 280003220 | 1.74 | 58 | Curative (C) | 2013-09-28 | 2013-09-28 | Carboplatin AUC 2 - 5 | N | null | 280027967 | CARBOPLATIN |
| 280004793 | 280003220 | 1.9 | 167 | Adjuvant (A) | 2017-10-17 | 2017-10-21 | EOX | null | null | 280027967 | EOX |
| 280004794 | 280003220 | 1.7 | 84.7 | Neo-adjuvant (N) | 2013-07-08 | 2013-07-29 | Carboplatin + Etoposide iv&po | N | Y | 280027967 | CARBOPLATIN + ETOPOSIDE |
| 280004795 | 280003220 | 1.62 | 58.2 | Palliative (P) | 2013-06-18 | 2013-06-28 | Carboplatin AUC 2 - 5 | N | N | 280027967 | CARBOPLATIN |
| 280004796 | 280003221 | 0 | null | Disease modification (D) | 2013-09-16 | 2013-09-22 | STS Non-Rhabdo EpSSG 2005 IVA | Y | N | 280027973 | NOT MATCHED |
| 280004797 | 280003222 | null | null | null | 2017-09-14 | 2017-09-28 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 280027974 | CISPLATIN + GEMCITABINE |
| 280004798 | 280003222 | null | 77.1 | Curative (C) | 2017-06-06 | 2017-06-06 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | 280027974 | NOT MATCHED |
| 280004799 | 280003222 | 1.77 | 72.1 | Curative (C) | 2015-09-16 | 2015-09-16 | Carboplatin + Etoposide iv&po | N | Y | 280027974 | CARBOPLATIN + ETOPOSIDE |
| 280004800 | 280003222 | null | 72.6 | Curative (C) | 2017-11-14 | 2017-12-01 | EOX | null | null | 280027974 | EOX |
| 280004801 | 280003222 | 1.68 | 91.3 | Neo-adjuvant (N) | 2016-09-05 | 2016-10-03 | CARBOPLATIN + RT | N | N | 280027974 | CARBOPLATIN + RT |
| 280004802 | 280003223 | null | 96.2 | Curative (C) | 2017-07-03 | 2017-07-31 | Carboplatin AUC 6 - 10 | 02 | Y | 280027980 | CARBOPLATIN |
| 280004803 | 280003223 | 1.58 | 78 | Curative (C) | 2015-12-02 | 2015-12-14 | Trial Unspecified | 02 | Y | 280027980 | TRIAL |
| 280004804 | 280003224 | 1.86 | 87.6 | null | 2018-04-12 | 2018-04-20 | Carboplatin AUC 6 - 10 | N | N | 280027984 | CARBOPLATIN |
| 280004805 | 280003225 | 1.58 | 78 | null | 2016-06-16 | 2016-06-16 | EW EuroEwing 2012 Arm B VDC | 02 | Y | 280027986 | TRIAL |
| 280004806 | 280007651 | 1.82 | 110 | Curative (C) | 2015-06-20 | 2015-06-20 | Carboplatin + Etoposide iv&po | N | N | 280027987 | CARBOPLATIN + ETOPOSIDE |
| 280004807 | 280007651 | null | 77.65 | Curative (C) | 2017-11-06 | 2017-11-06 | Cetuximab 7 day (Cycle 1) | N | Y | 280027987 | CETUXIMAB |
| 280004808 | 280003226 | 1.66 | 59 | Curative (C) | 2016-06-25 | 2016-07-12 | CARBOPLATIN + RT | 02 | Y | 280027990 | CARBOPLATIN + RT |
| 280004809 | 280003226 | 1.6 | 68 | Palliative (P) | 2015-02-06 | 2015-02-06 | CETUXIMAB | Y | Y | 280027990 | CETUXIMAB |
| 280004810 | 280003226 | 1.6 | 60.2 | Curative (C) | 2017-01-25 | 2017-02-01 | Cetuximab 7 day (Cycle 1) | Y | Y | 280027990 | CETUXIMAB |
| 280004811 | 280003227 | 1.56 | 73.4 | Curative (C) | 2016-01-04 | 2016-01-04 | Carboplatin + Etoposide iv&po | Y | Y | 280027995 | CARBOPLATIN + ETOPOSIDE |
| 280004812 | 280003228 | 1.86 | 73 | Not known (9) | 2015-05-25 | 2015-06-22 | Carboplatin AUC 6 - 10 | 02 | Y | 280027996 | CARBOPLATIN |
| 280004813 | 280003228 | 1.7 | 96.9 | Curative (C) | 2014-08-17 | 2014-08-28 | CARBOPLATIN + ETOPOSIDE | 01 | null | 280027996 | CARBOPLATIN + ETOPOSIDE |
| 280004814 | 280003229 | 1.73 | null | Palliative (P) | 2016-06-28 | 2016-07-01 | Trial Unspecified | N | N | 280027998 | TRIAL |
| 280004815 | 280003229 | 1.71 | 116.5 | Curative (C) | 2014-07-25 | 2014-07-27 | Carboplatin + Etoposide iv&po | N | Y | 280027998 | CARBOPLATIN + ETOPOSIDE |
| 280004816 | 280003229 | 1.66 | null | Curative (C) | 2015-07-03 | 2015-07-06 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 280027998 | CISPLATIN + GEMCITABINE |
| 280004817 | 280003229 | 1.69 | null | Adjuvant (A) | 2017-12-04 | 2017-12-14 | CETUXIMAB | 2 | N | 280027998 | CETUXIMAB |
| 280004818 | 280011578 | null | 116 | Neo-adjuvant (N) | 2015-02-21 | 2015-03-20 | CARBOPLATIN + RT | N | Y | 280028007 | CARBOPLATIN + RT |
| 280004819 | 280003230 | 1.78 | 86.5 | Curative (C) | 2013-05-01 | 2013-05-30 | CARBOPLATIN + RT | N | Y | 280028008 | CARBOPLATIN + RT |
| 280004820 | 280007655 | 1.65 | 74.5 | Curative (C) | 2015-11-08 | 2015-11-15 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | 280028009 | CARBOPLATIN + PACLITAXEL |
| 280004821 | 280003231 | 1.66 | 63 | Curative (C) | 2017-05-12 | 2017-05-19 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | null | 280028010 | CISPLATIN + GEMCITABINE |
| 280004822 | 280003232 | 1.9 | 64.6 | Curative (C) | 2017-10-29 | 2017-11-09 | Carboplatin AUC 6 - 10 | N | Y | 280028011 | CARBOPLATIN |
| 280004823 | 280007656 | 1.69 | 58.2 | Curative (C) | 2015-05-19 | 2015-12-31 | EW EuroEwing 2012 Arm B IE | N | N | 280028013 | TRIAL |
| 280004824 | 280009905 | 1.78 | 109 | Palliative (P) | 2014-08-20 | 2014-09-20 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280028015 | CISPLATIN + GEMCITABINE |
| 280004825 | 280003233 | 1.69 | 69.9 | Palliative (P) | 2017-11-11 | 2017-11-15 | CARBOPLATIN + ETOPOSIDE | null | N | 280028016 | CARBOPLATIN + ETOPOSIDE |
| 280004826 | 280003234 | 1.45 | 63.3 | Palliative (P) | 2015-06-05 | 2015-07-03 | Carboplatin AUC 2 - 5 | N | Y | 280028020 | CARBOPLATIN |
| 280004827 | 280007657 | 1.65 | 53.2 | Palliative (P) | 2016-08-20 | 2016-09-15 | Cetuximab 7 day (Cycle 1) | Y | N | 280028021 | CETUXIMAB |